Iodinated contrast media (ICM) induced acute kidney injury (AKI) accounts for 11% of cases
of AKI and is its third most common cause in hospitalized patients. However, the …

Contrast-induced nephropathy (CIN) is reversible acute renal failure observed following
administration of iodinated contrast media (CM) during angiographic or other medical …

Objectives: This study sought to determine if in addition to standard preventive measures on-
admission, high-dose rosuvastatin exerts a protective effect against contrast-induced acute …

Objectives: This study sought to evaluate the safety and efficacy of rosuvastatin in preventing
contrast-induced acute kidney injury (CI-AKI) in patients with diabetes mellitus (DM) and …

Background A few studies focused on statin therapy as specific prophylactic measures of
contrast-induced nephropathy have been published with conflicting results. In this meta …

We investigated the relationship between baseline neutrophil-to-lymphocyte ratio (NLR) and
contrast-induced nephropathy (CIN) in patients with ST-segment elevation myocardial …

Background Contrast-induced acute kidney injury is an adverse outcome resulting from
radiocontrast medium exposure during coronary angiography and percutaneous coronary …

Background Contrast-induced nephropathy (CIN) is an important cause of acute renal
failure. We observe the effect of rosuvastatin on preventing CIN in diabetic rats in current …

Background The results of previous studies have been contradictory in terms of the efficacy
of statin treatment in preventing contrast-induced acute kidney injury (CI-AKI) and clinical …

Background Results of studies on the efficacy of atorvastatin pretreatment on reducing the
prevalence of contrast-induced acute kidney injury (CIAKI) in patients undergoing coronary …